FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Tysabri may help heal MS patients' nerves

Tools

The Biogen Idec/Elan drug Tysabri may offer an important benefit that helps balance its risk of the potentially fatal brain infection primary multifocal leukoencephalopathy: A small new study suggests the drug promotes healing around the frayed nerves of multiple sclerosis patients. "What we have seen in these...data suggest that Tysabri may have the capacity to repair and possibly restore some of the damaged myelin sheath that protects nerve fibers," the study's lead author said in a Biogen statement. ReleaseReport


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about Biogen Idec   Clinical Trial Results   multiple sclerosis   Tysabri   Elan